Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CHKA | P35790 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.35 |
| ▸ | CHRNA6 | Q15825 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16616375 | 0.98 | CA2 (0.37) | CA2CA12CA1CA9CHKA | |
| SCHEMBL1764108 | 0.92 | CA2 (0.36) | CA2CA12CA1CA9CHKA | |
| SCHEMBL16057898 | 0.86 | — | — | |
| Pyrrolidine SCHEMBL2830893 | 0.85 | CA2 (0.38) | CA2CA12CA1CA9CHKA | |
| SCHEMBL28062708 | 0.82 | CA2 (0.41) | CA2CA12CA1CA9CHKA | |
| SCHEMBL5149419 | 0.82 | — | — | |
| SCHEMBL5874622 | 0.80 | CA2 (0.41) | CA2CA12CA1CA9CHKA | |
| SCHEMBL5875153 | 0.80 | CA2 (0.41) | CA2CA12CA1CA9CHKA | |
| SCHEMBL4958163 | 0.78 | CA2 (0.39) | CA2CA12CA1CA9CHKA | |
| SCHEMBL790285 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116764689-A | Method for stripping carbamate from ion exchange resin | 埃克-泰克股份有限公司 | 2023-09-19 | — | — | CN | claimed |
| US-10898891-B2 | Process for stripping carbamate from ion exchange resin | ECO-TEC LTD. (CA) | 2021-01-26 | — | — | US | claimed |
| US-20190009268-A1 | Process for Stripping Carbamate from Ion Exchange Resin | CERBERUS BUSINESS FINANCE AGENCY, LLC, AS COLLATERAL AGENT | 2019-01-10 | — | — | US | claimed |
| EP-3337612-A1 | PROCESS FOR STRIPPING CARBAMATE FROM ION EXCHANGE RESIN | Eco-Tec Ltd. (CA) | 2018-06-27 | — | — | EP | claimed |
| CN-107921430-A | Method for stripping carbamate from ion exchange resin | ECO-TEC有限公司 | 2018-04-17 | — | — | CN | claimed |
| CN-102464612-B | Dihalide propylene ether compound containing piperazine carbamic acid ester and application | SINOCHEM CORP | 2014-12-24 | — | — | CN | claimed |
| CN-102464612-A | Dihalide propylene ether compound containing piperazine carbamic acid ester and application | SINOCHEM CORP | 2012-05-23 | — | — | CN | claimed |
| US-7388026-B2 | Prodrugs of CC-1065 analogs | IMMUNOGEN, INC. (US) | 2008-06-17 | — | — | US | claimed |
| US-20250049968-A1 | THERAPEUTIC AND IMAGING AGENTS FOR TARGETING MYOCARDIAL TISSUE | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2025-02-13 | — | — | US | disclosed |
| EP-2950910-B1 | CARBON CAPTURE SOLVENTS AND METHODS FOR USING SUCH SOLVENTS | CARBON CLEAN SOLUTIONS LTD (GB) | 2024-12-11 | — | — | EP | disclosed |
| CN-118454413-B | Carbon dioxide absorbent, carbon dioxide capturing system and application method | 苏州优碳科技有限公司 | 2024-11-22 | — | — | CN | disclosed |
| EP-4427835-A1 | CARBON CAPTURE SOLVENTS AND METHODS FOR USING SUCH SOLVENTS | Carbon Clean Solutions Limited (GB) | 2024-09-11 | — | — | EP | disclosed |
| CN-118615832-A | Electronic grade high-purity carbon dioxide capturing system and capturing method | 苏州优碳科技有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-118454413-A | Carbon dioxide absorbent, carbon dioxide capturing system and application method | 苏州优碳科技有限公司 | 2024-08-09 | — | — | CN | disclosed |
| EP-0350950-A1 | Process for the preparation of quinoline antibacterial compounds | ABBOTT LABORATORIES (US) | 1990-01-17 | — | — | EP | disclosed |
| US-4705673-A | Mixed solvent system for treating acidic gas | UNION CARBIDE CORPORATION (US) | 1987-11-10 | — | — | US | disclosed |
| EP-0084162-B1 | VULCANIZABLE EPOXIDE-CONTAINING ETHYLENE COPOLYMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-09-23 | — | — | EP | disclosed |
| US-4381378-A | Method for vulcanizing ethylene/acrylic or vinyl ester/glycidyl(meth)acrylate copolymer with piperazinium dicarboxylate salt and composition for same | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-04-26 | — | — | US | disclosed |
| US-4336233-A | Removal of CO2 and/or H2 S and/or COS from gases containing these constituents | BASF AKTIENGESELLSCHAFT (DE) | 1982-06-22 | — | — | US | disclosed |
| US-3810897-A | N-SUBSTITUTED-N-ALKANOL PIPERAZINE CARBAMATES AND ACID ADDITION SALTS THEREOF | FERLUX | 1974-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049968-A1 | THERAPEUTIC AND IMAGING AGENTS FOR TARGETING MYOCARDIAL TISSUE | MYLK2, MYOF, MYL6 | CA2 2216/4885CA12 2471/4885CA1 3344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.